Provided by Tiger Trade Technology Pte. Ltd.

Doximity, Inc.

24.41
-0.3900-1.57%
Post-market: 24.410.00000.00%17:00 EDT
Volume:5.11M
Turnover:125.05M
Market Cap:4.51B
PE:20.52
High:24.95
Open:24.69
Low:24.24
Close:24.80
52wk High:76.51
52wk Low:23.53
Shares:184.71M
Float Shares:133.13M
Volume Ratio:2.43
T/O Rate:3.84%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.19
EPS(LYR):1.11
ROE:23.82%
ROA:12.84%
PB:4.60
PE(LYR):21.99

Loading ...

U.S. RESEARCH ROUNDUP-AstraZeneca, Confluent, Pepsico

Reuters
·
Dec 09, 2025

Doximity Director Kira Scherer Wampler Reports Disposal of Common Shares

Reuters
·
Dec 04, 2025

Berenberg Bank Reaffirms Their Buy Rating on Dr. Martens Plc (DOCS)

TIPRANKS
·
Nov 29, 2025

Doximity Director Timothy S. Cabral Reports Disposal of Common Shares

Reuters
·
Nov 25, 2025

Dr. Martens Earnings Call: Mixed Sentiments and Strategic Moves

TIPRANKS
·
Nov 22, 2025

BUZZ-U.S. STOCKS ON THE MOVE-IES Holding, Eli Lilly, Alphabet

Reuters
·
Nov 22, 2025

BUZZ-Doximity rises after Raymond James upgrades to 'strong buy'

Reuters
·
Nov 22, 2025

Doximity Shares up 2.6% Premarket After Raymond James Raises to Strong Buy From Outperform

THOMSON REUTERS
·
Nov 21, 2025

Doximity Inc : Raymond James Raises to Strong Buy From Outperform; Cuts Target Price to $65 From $75

THOMSON REUTERS
·
Nov 21, 2025

Dr. Martens Plc (DOCS) Gets a Hold from Barclays

TIPRANKS
·
Nov 21, 2025

Goldman Sachs Sticks to Their Hold Rating for Dr. Martens Plc (DOCS)

TIPRANKS
·
Nov 21, 2025

Peel Hunt Reaffirms Their Buy Rating on Dr. Martens Plc (DOCS)

TIPRANKS
·
Nov 21, 2025

Can Doximity’s (DOCS) Share Buybacks and Earnings Strength Tell Us More About Its Growth Vision?

Simply Wall St.
·
Nov 20, 2025

Jim Cramer: Don't Buy This Health Care Stock Yet, It Is 'Still Too Expensive'

Benzinga_recent_news
·
Nov 13, 2025

Dr. Martens Directors Participate in Share Incentive Plan

TIPRANKS
·
Nov 12, 2025

Dr. Martens Plc (DOCS) Receives a Hold from RBC Capital

TIPRANKS
·
Nov 12, 2025

Analysts Conflicted on These Healthcare Names: Madrigal Pharmaceuticals (MDGL), Doximity (DOCS) and Sutro Biopharma (STRO)

TIPRANKS
·
Nov 11, 2025

Doximity Is Maintained at Hold by Canaccord Genuity

Dow Jones
·
Nov 11, 2025

OpenAI considers consumer health tools in push beyond core AI offerings, Business Insider reports

Reuters
·
Nov 10, 2025

Stock Track | Doximity Plummets 14.73% as Q2 Beat Overshadowed by Disappointing Growth Outlook

Stock Track
·
Nov 08, 2025